vTv Therapeutics Q3 EPS $(0.08) Down From $(0.05) YoY
Portfolio Pulse from Benzinga Newsdesk
vTv Therapeutics reported Q3 losses of $(0.08) per share, a 60% increase from $(0.05) per share losses in the same period last year.
November 09, 2023 | 11:52 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
vTv Therapeutics reported a 60% increase in losses per share in Q3 YoY, which may negatively impact investor sentiment.
vTv Therapeutics reported a significant increase in losses per share for Q3 compared to the same period last year. This is likely to negatively impact the stock as it indicates a worsening financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100